[{"ticker": "AE", "queryCount": 2, "resultsCount": 2, "adjusted": true, "results": [{"v": 5605, "vw": 24.0198, "o": 23.99, "c": 23.85, "h": 24.35, "l": 23.75, "t": 1705899600000, "n": 208}, {"v": 5875, "vw": 23.8713, "o": 23.85, "c": 23.8, "h": 24.15, "l": 23.8, "t": 1705986000000, "n": 219}], "status": "OK", "request_id": "55892db64dd4c4b66e1644944cee1379", "count": 2}, {"stories": [{"id": "-1277157401698737396", "title": "Adams Resources GAAP EPS of $0.88 beats by $1.13, revenue of $760.6M beats by $60.54M", "url": "https://seekingalpha.com/news/4033433-adams-resources-gaap-eps-of-0_88-beats-1_13-revenue-of-760_6m-beats-60_54m", "site": "seekingalpha.com", "time": 1699478974000, "favicon_url": "https://static.tickertick.com/website_icons/seekingalpha.com.ico", "tags": ["ae"], "tickers": ["ae"]}], "last_id": "-1277157401698737396"}, {"ticker": "AIM", "queryCount": 2, "resultsCount": 2, "adjusted": true, "results": [{"v": 244352, "vw": 0.4261, "o": 0.43, "c": 0.4185, "h": 0.435, "l": 0.415, "t": 1705899600000, "n": 635}, {"v": 134521, "vw": 0.4287, "o": 0.449, "c": 0.43, "h": 0.449, "l": 0.42, "t": 1705986000000, "n": 396}], "status": "OK", "request_id": "aa6e99c38af25fcf4cc2248cf1979573", "count": 2}, {"stories": [{"id": "-3499051497430225502", "title": "AIM ImmunoTech Announces that the First Subject is Enrolled in the Phase 1b/2 Study Evaluating Ampligen\u00ae in Combination with AstraZeneca\u2019s Imfinzi\u00ae for the Treatment of Late-Stage Pancreatic Cancer", "url": "https://www.biospace.com/article/releases/aim-immunotech-announces-that-the-first-subject-is-enrolled-in-the-phase-1b-2-study-evaluating-ampligen-in-combination-with-astrazeneca-s-imfinzi-for-the-treatment-of-late-stage-pancreatic-cancer-/?s=65", "site": "biospace.com", "time": 1705881600000, "favicon_url": "https://static.tickertick.com/website_icons/biospace.com.ico", "tags": ["aim"], "description": "AIM ImmunoTech Inc. today announced that the first subject has been enrolled at Erasmus Medical Center (\u201cErasmus MC\u201d) in a Phase 1b/2 clinical trial combining AIM\u2019s Ampligen \u00ae (rintatolimod) with AstraZeneca\u2019s anti-PD-L1 immune checkpoint inhibitor Imfinzi \u00ae (durvalumab) for the treatment of late-stage pancreatic cancer (the \u201cDURIPANC Study\u201d).", "tickers": ["aim"]}], "last_id": "-3499051497430225502"}, {"ticker": "AREN", "queryCount": 2, "resultsCount": 2, "adjusted": true, "results": [{"v": 267688, "vw": 0.82, "o": 0.8332, "c": 0.8311, "h": 0.8641, "l": 0.7703, "t": 1705899600000, "n": 821}, {"v": 231503, "vw": 0.8108, "o": 0.832, "c": 0.8319, "h": 0.863, "l": 0.79, "t": 1705986000000, "n": 744}], "status": "OK", "request_id": "f24f6322b6c5edd1452de2b2afb4b7a3", "count": 2}, {"stories": [{"id": "-373649205628868684", "title": "Arena Group\u2019s stock plummets over 30% after losing rights to Sports Illustrated, laying off staff", "url": "https://www.marketwatch.com/story/arena-groups-stock-plummets-over-30-after-losing-rights-to-sports-illustrated-laying-off-staff-a7e8045c?mod=mw_rss_topstories", "site": "marketwatch.com", "time": 1705701240000, "favicon_url": "https://static.tickertick.com/website_icons/marketwatch.com.ico", "tags": ["aren"], "description": "Shares of Arena Group Holdings Inc. dropped more than 30% on Friday after the ailing media company lost its license to publish Sports Illustrated and the union for the famed publication said \"possibly all\" union-member staff could be laid off as a result.", "tickers": ["aren"]}], "last_id": "-373649205628868684"}, {"ticker": "ARMP", "queryCount": 2, "resultsCount": 2, "adjusted": true, "results": [{"v": 32903, "vw": 3.8938, "o": 3.85, "c": 3.88, "h": 3.9699, "l": 3.77, "t": 1705899600000, "n": 262}, {"v": 11782, "vw": 3.9436, "o": 4, "c": 3.9, "h": 4, "l": 3.88, "t": 1705986000000, "n": 131}], "status": "OK", "request_id": "1f39abe2e64fce4c4d4e14451658f860", "count": 2}, {"stories": [{"id": "-6749175214018222013", "title": "Kneecap film: Irish language rappers head stateside for Sundance", "url": "https://www.bbc.co.uk/news/uk-northern-ireland-67998896?at_medium=RSS&at_campaign=KARANGA", "site": "bbc.co.uk", "time": 1705472364000, "favicon_url": "https://static.tickertick.com/website_icons/bbc.co.uk.ico", "tags": ["armp"], "description": "Kneecap will become the first Irish language feature film to premier at Sundance Film Festival.", "tickers": ["armp"]}], "last_id": "-6749175214018222013"}, {"ticker": "ASM", "queryCount": 2, "resultsCount": 2, "adjusted": true, "results": [{"v": 241807, "vw": 0.4617, "o": 0.4663, "c": 0.4624, "h": 0.471299, "l": 0.451, "t": 1705899600000, "n": 395}, {"v": 339094, "vw": 0.4634, "o": 0.4658, "c": 0.4701, "h": 0.474, "l": 0.4535, "t": 1705986000000, "n": 769}], "status": "OK", "request_id": "31a3be172a99c6cd12b594ce36b16ae6", "count": 2}, {"stories": []}]